Page last updated: 2024-12-08
3-acryloxypropyltrimethoxysilane
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 151204 |
| SCHEMBL ID | 71730 |
| MeSH ID | M0247528 |
Synonyms (38)
| Synonym |
|---|
| 3-acryloxypropyltrimethoxysilane, stab. with 100ppm bht |
| c9h18o5si |
| 3-acryloxypropyltrimethoxysilane , |
| 3-(trimethoxysilyl)propyl 2-propenoate |
| 2-propenoic acid, 3-(trimethoxysilyl)propyl ester |
| 3-(trimethoxysilyl)propyl acrylate, 92%, contains 100 ppm bht as inhibitor |
| 3-(acryloyloxy)propyltrimethoxysilane , |
| 4369-14-6 |
| 3-(trimethoxysilyl)propyl acrylate |
| acrylic acid 3-(trimethoxysilyl)propyl ester |
| 3-trimethoxysilylpropyl prop-2-enoate |
| (3-acryloxypropyl)(trimethoxy)silane |
| ec 419-560-6 |
| acrylic acid, 3-(trimethoxysilyl)propyl ester |
| FT-0604691 |
| AKOS015903559 |
| (3-acryloxypropyl)trimethoxysilane contains 100 ppm bht as inhibitor |
| S00155 |
| SCHEMBL71730 |
| DTXSID6063436 |
| 3-acryloyloxypropyltrimethoxysilane |
| (3-acryloxypropyl)trimethoxysilane |
| mfcd00054803 |
| CS-W004495 |
| 3-(trimethoxysilyl)propylacrylate |
| 3-(acryloxy)propyltrimethoxysilane |
| 3-(trimethoxysilyl)propyl prop-2-enoate |
| gamma-acryloxypropyltrimethoxysilane |
| KBQVDAIIQCXKPI-UHFFFAOYSA-N |
| SY048259 |
| 3-(trimethoxysilyl)propyl acrylate, (stabilized with bht) |
| 3-(trimethoxysilyl)propyl acrylate (stabilized with bht) |
| AS-15099 |
| 5-iodo-2-furoicacid,97% |
| I11114 |
| 3-acryloxy propyltrimethoxysilane |
| 3-acryloxypropyltrimethoxysilane(92%) |
| 160716-45-0 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 28.86
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (28.86) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (12.50%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (87.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||